We therefore evaluated T‐cell activation by measuring the levels of interferon‐γ (IFN‐γ) and interleukin 2 (IL‐2) in tumor tissues using an enzyme‐linked immunosorbent assay (ELISA). The gene discussed is IL2; the disease is neoplasm.